Genzyme cleared for additional manufacturing in Ireland (Pharmaceutical Business Review)
The FDA has approved the fill/finishing, packaging and labeling of Thymoglobulin at Genzymes state-of-the-art Waterford, Ireland facility. The approval allows Genzyme to begin manufacturing and distribution of Thymoglobulin, a product for the treatment of acute rejection in patients with a kidney transplant, from this single location.

Immucor Announces Record Fiscal Fourth Quarter and Record Year End Results (FinanzNachrichten)
NORCROSS, Ga., July 26 /PRNewswire-FirstCall/ -- Immucor, ( Nachrichten ) Inc. , the global leader in providing automated instrument-reagent systems to the blood transfusion industry, today reported financial results for the fiscal fourth quarter and year ended May 31, 2006.

FDA vows more info on adviser conflicts (The Star-Ledger)
WASHINGTON -- A top Food and Drug Administration official yesterday promised fuller disclosure of industry ties to scientists and doctors who serve on advisory panels that recommend whether to approve new pharmaceuticals and medical devices.